The study appeared in the Journal of the American Medical Association and prompted the World Health Organization (WHO) to recommend the use of the medicines Tocilizumab and sarilumab are used to treat rheumatoid arthritis, an autoimmune condition Arthritis drugs tocilizumab and sarilumab reduce the risk of death and the need...